MULTIVARIANT META-ANALYSIS OF KRAS MUTATIONS'S PREDICTIVE VALUE FOR RESPONSE TO CETUXIMAB IN COLORECTAL CANCER

被引：0
作者：
Tsoukalas, N. [1 ,2 ]
Bagos, P. [2 ]
Hamodrakas, S. [2 ]
机构：
[1] 401 Gen Army Hosp, Athens, Greece
[2] Univ Athens, Fac Biol, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
[41]   KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis [J].
Du, Lijun ;
Kim, John J. ;
Shen, Jinhua ;
Chen, Binrui ;
Dai, Ning .
ONCOTARGET, 2017, 8 (13) :22175-22186
[42]   Prognostic value of BRAF and KRAS mutations in colorectal cancer patients [J].
Murata, Paola ;
Stradella, Agostina ;
Paez, David ;
Tobena, Maria ;
Sebio, Ana ;
Pare, Laia ;
Gonzalez, Alan ;
Espinosa, Inigo ;
Targarona, Eduardo ;
Gich, Ignasi ;
Barnadas, Agust ;
Baiget, Montserrat ;
Martin-Richard, Marta .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[43]   PROGNOSTIC VALUE OF BRAF AND KRAS MUTATIONS IN COLORECTAL CANCER PATIENTS [J].
Murata, E. P. ;
Stradella, A. ;
Paez, D. ;
Tobena Puyal, M. ;
Sebio Garcia, A. ;
Gonzalez, A. ;
Targarona, E. ;
Baiget, M. ;
Barnadas, A. ;
Martin-Richard, M. .
ANNALS OF ONCOLOGY, 2012, 23 :216-216
[44]   Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2 [J].
Boeckx, Nele ;
Peeters, Marc ;
Van Camp, Guy ;
Pauwels, Patrick ;
de Beeck, Ken Op ;
Deschoolmeester, Vanessa .
DRUGS, 2015, 75 (15) :1739-1756
[45]   Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2 [J].
Nele Boeckx ;
Marc Peeters ;
Guy Van Camp ;
Patrick Pauwels ;
Ken Op de Beeck ;
Vanessa Deschoolmeester .
Drugs, 2015, 75 :1739-1756
[46]   Prognostic value of microRNAs in colorectal cancer: a meta-analysis [J].
Gao, Song ;
Zhao, Zhi-Ying ;
Wu, Rong ;
Zhang, Yue ;
Zhang, Zhen-Yong .
CANCER MANAGEMENT AND RESEARCH, 2018, 10 :907-929
[47]   Value of bevacizumab in treatment of colorectal cancer: A meta-analysis [J].
Chun-Ying Qu ;
Ying Zheng ;
Min Zhou ;
Yi Zhang ;
Feng Shen ;
Jia Cao ;
Lei-Ming Xu .
World Journal of Gastroenterology, 2015, (16) :5072-5080
[48]   Value of bevacizumab in treatment of colorectal cancer: A meta-analysis [J].
Qu, Chun-Ying ;
Zheng, Ying ;
Zhou, Min ;
Zhang, Yi ;
Shen, Feng ;
Cao, Jia ;
Xu, Lei-Ming .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (16) :5072-5080
[49]   Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis [J].
Han, Susu ;
Yang, Wei ;
Zong, Shaoqi ;
Li, Hongjia ;
Liu, Shanshan ;
Li, Wen ;
Shi, Qi ;
Hou, Fenggang .
ONCOTARGET, 2017, 8 (38) :64373-64384
[50]   KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J].
Lievre, Astrid ;
Bachet, Jean-Baptiste ;
Boige, Valerie ;
Cayre, Anne ;
Le Corre, Delphine ;
Buc, Emmanuel ;
Ychou, Marc ;
Bouche, Olivier ;
Landi, Bruno ;
Louvet, Christophe ;
Andre, Thierry ;
Bibeau, Frederic ;
Diebold, Marie-Daniele ;
Rougier, Philippe ;
Ducreux, Michel ;
Tomasic, Gorana ;
Emile, Jean-Francois ;
Penault-Llorca, Frederique ;
Laurent-Puig, Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :374-379
12345